Thomas F. Gajewski
No más puestos en curso
Perfil
Thomas F.
Gajewski is the founder of Jounce Therapeutics, Inc. (founded in 2013).
Dr. Gajewski is also the founder of Pyxis Oncology, Inc. He received his undergraduate and doctorate degrees from The University of Chicago.
Antiguos cargos conocidos de Thomas F. Gajewski.
| Empresas | Cargo | Fin |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Fundador | - |
| JOUNCE THERAPEUTICS, INC. | Fundador | - |
Formación de Thomas F. Gajewski.
| The University of Chicago | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Thomas F. Gajewski
